Join
Live feed
·
INSIDERFilingvia Quantisnow
Avenue Therapeutics Inc. logo

SEC Form 4: Fortress Biotech, Inc. bought $301,255 worth of shares (418,410 units at $0.72), increasing direct ownership by 68% to 1,032,390 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATXI (Avenue Therapeutics Inc.) and more on Quantisnow.